Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 1000 mg Tablets Under Fed Conditions.

NCT07633041 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence Study in Healthy Subjects

Interventions

DRUG: Synjardy 12.5/1000 mg tablet
DRUG: Empagliflozin/metformin 12.5/1000 mg

Sponsor

ADIUM